We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYN icon
1926
Rayonier
RYN
$6.54B
$2.19M ﹤0.01%
64,561
+10,714
+20% +$393K
LEAD
1927
DELISTED
Siren DIVCON Leaders Dividend ETF
LEAD
$2.19M ﹤0.01%
46,275
-1,565
-3% -$79.8K
MAIN icon
1928
Main Street Capital
MAIN
$5.54B
$2.18M ﹤0.01%
56,647
-2,131
-4% -$83.3K
BGS icon
1929
B&G Foods
BGS
$299M
$2.17M ﹤0.01%
91,419
-13,650
-13% -$339K
ILCG icon
1930
iShares Morningstar Growth ETF
ILCG
$3.3B
$2.17M ﹤0.01%
43,361
+489
+1% +$27.1K
KBWD icon
1931
Invesco KBW High Dividend Yield Financial ETF
KBWD
$433M
$2.17M ﹤0.01%
132,129
-6,711
-5% -$120K
SANM icon
1932
Sanmina
SANM
$11.1B
$2.17M ﹤0.01%
53,255
-62,811
-54% -$2.6M
DKL icon
1933
Delek Logistics
DKL
$2.78B
$2.17M ﹤0.01%
44,494
+6,000
+16% +$303K
GTHX
1934
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.16M ﹤0.01%
438,156
+40,277
+10% +$223K
RVLV icon
1935
Revolve Group
RVLV
$1.72B
$2.16M ﹤0.01%
83,232
+25,819
+45% +$953K
FAPR icon
1936
FT Vest US Equity Buffer ETF April
FAPR
$1.3B
$2.15M ﹤0.01%
+75,913
New +$2.27M
GOF icon
1937
Guggenheim Strategic Opportunities Fund
GOF
$2.39B
$2.15M ﹤0.01%
133,630
-50,190
-27% -$889K
BGC icon
1938
BGC Group
BGC
$5.2B
$2.15M ﹤0.01%
636,742
+11,910
+2% +$41.5K
BGH
1939
Barings Global Short Duration High Yield Fund
BGH
$287M
$2.14M ﹤0.01%
164,592
+3,655
+2% +$52.2K
ENOV icon
1940
Enovis
ENOV
$1.48B
$2.13M ﹤0.01%
38,738
-14,814
-28% -$955K
APP icon
1941
Applovin
APP
$105B
$2.13M ﹤0.01%
61,843
+4,100
+7% +$165K
AMSF icon
1942
AMERISAFE
AMSF
$504M
$2.13M ﹤0.01%
40,887
+488
+1% +$23.8K
DFIN icon
1943
Donnelley Financial Solutions
DFIN
$1.22B
$2.13M ﹤0.01%
72,628
+4,936
+7% +$146K
SMTC icon
1944
Semtech
SMTC
$12.4B
$2.12M ﹤0.01%
+38,647
New +$2.33M
DBL
1945
DoubleLine Opportunistic Credit Fund
DBL
$282M
$2.11M ﹤0.01%
135,550
+6,436
+5% +$103K
FAD icon
1946
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$599M
$2.11M ﹤0.01%
23,018
-1,451
-6% -$146K
TRS icon
1947
TriMas Corp
TRS
$1.39B
$2.1M ﹤0.01%
75,994
+22,247
+41% +$643K
SPHQ icon
1948
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
$2.1M ﹤0.01%
50,080
+5,470
+12% +$251K
FIF
1949
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
$2.1M ﹤0.01%
146,717
-37,047
-20% -$550K
CAC icon
1950
Camden National
CAC
$996M
$2.1M ﹤0.01%
47,553
+1,674
+4% +$75.1K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.